Caption Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Caption Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-91,800	Closed	-$1.65M	–	1390
2020 Q2	$1.65M	Sell	91,800 -253,100	-73%	-$3.52M	0.06%	419
2020 Q1	$2.46M	Buy	+344,900	New	+$4.3M	0.14%	202
2019 Q3	–	Sell	-140,000	Closed	-$3.8M	–	977
2019 Q2	$3.8M	Buy	+140,000	New	+$4.39M	0.19%	155
2019 Q1	–	Sell	-127,100	Closed	-$2.48M	–	786
2018 Q4	$2.48M	Buy	127,100 +82,100	+182%	+$1.69M	0.2%	151
2018 Q3	$1.2M	Buy	+45,000	New	+$1.47M	0.07%	318

Caption Management's PTLA Position: Q3 2020 in Review

Caption Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 1,200 shares — an estimated $22K sold.

Caption Management first reported a position in PTLA in Q4 2018 and held it in 4 quarters. The position peaked at $1.95M in Q4 2018. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Caption Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Caption Management sold 1,200 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $22K.
Caption Management first reported a position in Portola Pharmaceuticals, Inc. in Q4 2018 and held it in 4 quarters.
Caption Management's Portola Pharmaceuticals, Inc. position peaked at $1.95M in Q4 2018.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Caption Management's 13F filing for Q3 2020, filed 16 Nov 2020.